[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

PL1802635T3 - Związki tricykliczne zawierające heteroatomy - Google Patents

Związki tricykliczne zawierające heteroatomy

Info

Publication number
PL1802635T3
PL1802635T3 PL05793907T PL05793907T PL1802635T3 PL 1802635 T3 PL1802635 T3 PL 1802635T3 PL 05793907 T PL05793907 T PL 05793907T PL 05793907 T PL05793907 T PL 05793907T PL 1802635 T3 PL1802635 T3 PL 1802635T3
Authority
PL
Poland
Prior art keywords
heteroatoms
tricyclic compounds
containing tricyclic
compounds
tricyclic
Prior art date
Application number
PL05793907T
Other languages
English (en)
Inventor
Maximilian Grassberger
Amarylla Horvath
Original Assignee
Meda Pharma S A R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0422643A external-priority patent/GB0422643D0/en
Priority claimed from GB0427599A external-priority patent/GB0427599D0/en
Application filed by Meda Pharma S A R L filed Critical Meda Pharma S A R L
Publication of PL1802635T3 publication Critical patent/PL1802635T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Pyridine Compounds (AREA)
PL05793907T 2004-10-12 2005-10-10 Związki tricykliczne zawierające heteroatomy PL1802635T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0422643A GB0422643D0 (en) 2004-10-12 2004-10-12 Organic compounds
GB0427599A GB0427599D0 (en) 2004-12-16 2004-12-16 Organic compounds
PCT/EP2005/010889 WO2006040111A2 (en) 2004-10-12 2005-10-10 Heteroatoms-containing tricyclic compounds
EP05793907.6A EP1802635B8 (en) 2004-10-12 2005-10-10 Heteroatoms-containing tricyclic compounds

Publications (1)

Publication Number Publication Date
PL1802635T3 true PL1802635T3 (pl) 2013-07-31

Family

ID=36084355

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05793907T PL1802635T3 (pl) 2004-10-12 2005-10-10 Związki tricykliczne zawierające heteroatomy

Country Status (28)

Country Link
US (1) US7514554B2 (pl)
EP (1) EP1802635B8 (pl)
JP (1) JP5032326B2 (pl)
KR (1) KR101228188B1 (pl)
CN (1) CN101031573B (pl)
AR (1) AR051386A1 (pl)
AU (1) AU2005293799B2 (pl)
BR (1) BRPI0516873A (pl)
CA (1) CA2581046C (pl)
DK (1) DK1802635T3 (pl)
EC (1) ECSP077384A (pl)
ES (1) ES2389206T3 (pl)
GT (1) GT200500282A (pl)
HK (1) HK1105634A1 (pl)
IL (1) IL182307A (pl)
JO (1) JO2727B1 (pl)
MA (1) MA28932B1 (pl)
MX (1) MX2007004258A (pl)
MY (1) MY140880A (pl)
NO (1) NO338603B1 (pl)
NZ (1) NZ554010A (pl)
PE (1) PE20060581A1 (pl)
PL (1) PL1802635T3 (pl)
PT (1) PT1802635E (pl)
RU (1) RU2394037C2 (pl)
TN (1) TNSN07133A1 (pl)
TW (1) TWI361192B (pl)
WO (1) WO2006040111A2 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007005222A (es) * 2004-12-01 2007-06-26 Teva Gyogyszergyar Zartkoruen Pimecrolimus amorfo no higroscopico y en polvo.
IT1394309B1 (it) 2009-05-22 2012-06-06 Poli Ind Chimica Spa Nuovo approccio chimico-enzimatico alla sintesi del pimecrolimus
EP3178824A1 (en) 2015-12-08 2017-06-14 Medichem, S.A. Process for preparing pimecrolimus
CN106854228B (zh) * 2015-12-08 2020-05-29 博瑞生物医药(苏州)股份有限公司 一种吡美莫司的制备方法
EP3619215B1 (en) 2017-05-01 2021-11-17 MEDA Pharma GmbH & Co. KG Process to convert crude ascomycin into purified pimecrolimus

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4464366A (en) 1979-12-19 1984-08-07 Ciba Geigy Corporation Cephem compounds having a terminal aminocarboxylic acid grouping and containing an azacyclyl(thio)ureido group
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
US5352671A (en) * 1989-11-09 1994-10-04 Sandoz Ltd. Heteroatoms-containing tricyclic compounds
ATE126803T1 (de) * 1989-11-09 1995-09-15 Sandoz Ag Heteroatome enthaltende tricyclische verbindungen.
EP0480623A1 (en) 1990-10-11 1992-04-15 Merck & Co. Inc. New halomacrolides and derivatives having immunosuppressive activity
MY110603A (en) 1993-05-27 1998-08-29 Novartis Ag Tetrahydropyran derivatives
US6160117A (en) 1997-11-06 2000-12-12 Zeneca Limited Chemical process
GB0012383D0 (en) 2000-05-22 2000-07-12 Novartis Ag Organic compounds
US6667312B2 (en) 2000-12-08 2003-12-23 3M Innovative Properties Company Thioether substituted imidazoquinolines

Also Published As

Publication number Publication date
PT1802635E (pt) 2012-08-21
CA2581046C (en) 2013-03-26
EP1802635B1 (en) 2012-06-06
JP2008515945A (ja) 2008-05-15
WO2006040111A2 (en) 2006-04-20
NO338603B1 (no) 2016-09-12
PE20060581A1 (es) 2006-08-17
AU2005293799B2 (en) 2009-02-26
KR20070063535A (ko) 2007-06-19
RU2394037C2 (ru) 2010-07-10
ES2389206T3 (es) 2012-10-24
MX2007004258A (es) 2007-05-11
EP1802635A2 (en) 2007-07-04
GT200500282A (es) 2006-05-04
MY140880A (en) 2010-01-29
TW200626603A (en) 2006-08-01
AR051386A1 (es) 2007-01-10
MA28932B1 (fr) 2007-10-01
KR101228188B1 (ko) 2013-01-30
WO2006040111A3 (en) 2006-06-22
CA2581046A1 (en) 2006-04-20
JP5032326B2 (ja) 2012-09-26
NZ554010A (en) 2009-10-30
CN101031573A (zh) 2007-09-05
EP1802635B8 (en) 2013-04-17
ECSP077384A (es) 2007-05-30
IL182307A0 (en) 2007-09-20
BRPI0516873A (pt) 2008-09-23
RU2007117497A (ru) 2008-11-20
US7514554B2 (en) 2009-04-07
DK1802635T3 (da) 2012-09-10
JO2727B1 (en) 2013-09-15
CN101031573B (zh) 2010-06-09
AU2005293799A1 (en) 2006-04-20
HK1105634A1 (en) 2008-02-22
US20080071082A1 (en) 2008-03-20
NO20072127L (no) 2007-06-08
TNSN07133A1 (en) 2008-11-21
TWI361192B (en) 2012-04-01
IL182307A (en) 2011-06-30

Similar Documents

Publication Publication Date Title
GB0405933D0 (en) Compounds
EP1737831A4 (en) NEUROLOGICALLY ACTIVE COMPOUNDS
GB0405193D0 (en) Compounds
HK1105634A1 (en) Heteroatoms-containing tricyclic compounds
GB0405272D0 (en) Compounds
GB0405267D0 (en) Compounds
EP1755617A4 (en) PERFLUORCARBON-SOLUBLE COMPOUNDS
GB0405101D0 (en) Compounds
GB0401269D0 (en) Compounds
GB0405280D0 (en) Compounds
GB0403593D0 (en) Compounds
GB0405893D0 (en) Compounds
ZA200702419B (en) Heteroatoms-containing tricyclic compounds
GB0403595D0 (en) Compounds
GB0419089D0 (en) Novel benzodiazepine compounds
GB0419088D0 (en) Novel benzodiazepine compounds
GB0403993D0 (en) Compounds
GB0401654D0 (en) Compounds
GB0403594D0 (en) Compounds
GB0403267D0 (en) Compounds
GB0403990D0 (en) Compounds
GB0401657D0 (en) Compounds
GB0403998D0 (en) Compounds
GB0404081D0 (en) Compounds
GB0404083D0 (en) Compounds